{"id":{"repo_id":"umkc","oai_identifier":"oai:mospace.umsystem.edu:10355/69003"},"canonical_url":"https://search.dev.ndltd.org/etd/umkc/oai:mospace.umsystem.edu:10355/69003","repository":{"repo_id":"umkc","name":"University of Missouri - Kansas City","base_url":"https://mospace.umsystem.edu/oai/request"},"display":{"title":"Well-Being and Suicidality Among Transgender Youth After Gender-Affirming Medical Interventions","abstract":"Pubertal suppression and gender-affirming hormones have become accepted treatment in the management of gender dysphoria (GD) among transgender adolescents to relieve the distress associated with pubertal development and/or their existing secondary sex characteristics. This study is a longitudinal evaluation of the effectiveness of these approaches for improving psychological well-being and decreasing suicidality among transgender youth referred to a transgender health specialty clinic at a large children’s hospital. A total of 11 adolescents who had received pubertal suppression medication and a total of 47 youth (14 transmen and 33 transwomen; 43 adolescents and 4 young adults) who had received gender-affirming hormones were assessed at least two times: before the start of treatment and at least 3 months after treatment. After pubertal suppression medication, a non-significant increase in general well-being was observed while levels of suicidality remained the same. After gender affirming hormones, a significant increase in levels of general well-being and a significant decrease in levels of suicidality were observed. These findings suggest that pubertal suppression medication and gender-affirming hormones are valuable medical interventions with promising psychosocial outcomes for transgender youth.","abstract_html":"Pubertal suppression and gender-affirming hormones have become accepted treatment in the management of gender dysphoria (GD) among transgender adolescents to relieve the distress associated with pubertal development and/or their existing secondary sex characteristics. This study is a longitudinal evaluation of the effectiveness of these approaches for improving psychological well-being and decreasing suicidality among transgender youth referred to a transgender health specialty clinic at a large children’s hospital. A total of 11 adolescents who had received pubertal suppression medication and a total of 47 youth (14 transmen and 33 transwomen; 43 adolescents and 4 young adults) who had received gender-affirming hormones were assessed at least two times: before the start of treatment and at least 3 months after treatment. After pubertal suppression medication, a non-significant increase in general well-being was observed while levels of suicidality remained the same. After gender affirming hormones, a significant increase in levels of general well-being and a significant decrease in levels of suicidality were observed. These findings suggest that pubertal suppression medication and gender-affirming hormones are valuable medical interventions with promising psychosocial outcomes for transgender youth.","abstract_has_math":false,"creators":["Allen, Luke R."],"institution":"University of Missouri -- Kansas City","degree_name":"Ph.D. (Doctor of Philosophy)","degree_level":"Doctoral","degree_discipline":"Counseling Psychology (UMKC)","degree_department":null,"school":null,"contributors":[],"advisors":["Watson, Laurel B."],"committee_chairs":[],"committee_members":[],"year":2019,"date_issued":"2019","date_published":"2019","updated_at":"2026-07-24T05:18:22Z","subjects":[],"languages":["en_US"],"rights":[],"rights_urls":[],"identifier_entries":[]},"links":{"outbound_url":"https://hdl.handle.net/10355/69003","outbound_label":"Handle","outbound_source":"dc:identifier.uri"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.advisor","label":"Advisor","values":["Watson, Laurel B."]},{"key":"dc:creator","label":"Author","values":["Allen, Luke R."]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.accessioned","label":"Dc Date Accessioned","values":["2019-06-12T14:02:02Z"]},{"key":"dc:date.available","label":"Dc Date Available","values":["2019-06-12T14:02:02Z"]},{"key":"dc:date.issued","label":"Date","values":["2019"]},{"key":"dc:publisher","label":"Institution","values":["University of Missouri -- Kansas City"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Counseling Psychology (UMKC)"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Doctoral"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Ph.D. (Doctor of Philosophy)"]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["University of Missouri--Kansas City"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.iso","label":"Language (ISO)","values":["en_US"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://hdl.handle.net/10355/69003"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["Title from PDF of title page viewed June 20, 2019","Dissertation advisor: Laurel B. Watson","Vita","Includes bibliographical references (pages 47-65)","Thesis (Ph.D.)--School of Education. University of Missouri--Kansas City, 2019"]},{"key":"dc:description.abstract","label":"Abstract","values":["Pubertal suppression and gender-affirming hormones have become accepted treatment in the management of gender dysphoria (GD) among transgender adolescents to relieve the distress associated with pubertal development and/or their existing secondary sex characteristics. This study is a longitudinal evaluation of the effectiveness of these approaches for improving psychological well-being and decreasing suicidality among transgender youth referred to a transgender health specialty clinic at a large children’s hospital. A total of 11 adolescents who had received pubertal suppression medication and a total of 47 youth (14 transmen and 33 transwomen; 43 adolescents and 4 young adults) who had received gender-affirming hormones were assessed at least two times: before the start of treatment and at least 3 months after treatment. After pubertal suppression medication, a non-significant increase in general well-being was observed while levels of suicidality remained the same. After gender affirming hormones, a significant increase in levels of general well-being and a significant decrease in levels of suicidality were observed. These findings suggest that pubertal suppression medication and gender-affirming hormones are valuable medical interventions with promising psychosocial outcomes for transgender youth."]},{"key":"dc:title","label":"Title","values":["Well-Being and Suicidality Among Transgender Youth After Gender-Affirming Medical Interventions"]}]}],"canonical_facts":{"dc:contributor.advisor":["Watson, Laurel B."],"dc:creator":["Allen, Luke R."],"dc:date.accessioned":["2019-06-12T14:02:02Z"],"dc:date.available":["2019-06-12T14:02:02Z"],"dc:date.issued":["2019"],"dc:description":["Title from PDF of title page viewed June 20, 2019","Dissertation advisor: Laurel B. Watson","Vita","Includes bibliographical references (pages 47-65)","Thesis (Ph.D.)--School of Education. University of Missouri--Kansas City, 2019"],"dc:description.abstract":["Pubertal suppression and gender-affirming hormones have become accepted treatment in the management of gender dysphoria (GD) among transgender adolescents to relieve the distress associated with pubertal development and/or their existing secondary sex characteristics. This study is a longitudinal evaluation of the effectiveness of these approaches for improving psychological well-being and decreasing suicidality among transgender youth referred to a transgender health specialty clinic at a large children’s hospital. A total of 11 adolescents who had received pubertal suppression medication and a total of 47 youth (14 transmen and 33 transwomen; 43 adolescents and 4 young adults) who had received gender-affirming hormones were assessed at least two times: before the start of treatment and at least 3 months after treatment. After pubertal suppression medication, a non-significant increase in general well-being was observed while levels of suicidality remained the same. After gender affirming hormones, a significant increase in levels of general well-being and a significant decrease in levels of suicidality were observed. These findings suggest that pubertal suppression medication and gender-affirming hormones are valuable medical interventions with promising psychosocial outcomes for transgender youth."],"dc:identifier.uri":["https://hdl.handle.net/10355/69003"],"dc:language.iso":["en_US"],"dc:publisher":["University of Missouri -- Kansas City"],"dc:title":["Well-Being and Suicidality Among Transgender Youth After Gender-Affirming Medical Interventions"],"dc:type":["Thesis"],"thesis:degree_discipline":["Counseling Psychology (UMKC)"],"thesis:degree_level":["Doctoral"],"thesis:degree_name":["Ph.D. (Doctor of Philosophy)"],"thesis:institution_name":["University of Missouri--Kansas City"]},"updated_at":"2026-07-24T05:18:22Z"}